My update to you on the latest changes in the live offerings on Manhattan Street Capital;
InSitu Biologics - AnestaGel™. Pausing soon*. Eliminate the need for addictive opiates for pain management after surgery.
AnestaGel™ is a non-opioid pain relief drug based on technology created by scientists at the Cleveland Clinic. AnestaGel™ is expected to be used in post-operative surgical procedures. It may be a solution in relieving pain for broken bones, cosmetic surgery, hip/knee replacements, hernia, and more. This paradigm shift is in the early stages of an annual $90 billion market opportunity.
InSitu Biologics' focus on investors that have a tie to the healthcare continuum is producing rapid investing momentum. The reason sales reps, CEO’s, malpractice lawyers, and pain physicians are investing: the Matrix Biohydrogel Technology and AnestaGel product appear to be what the market has been waiting for. The third tier of shares is nearly sold out. InSitu Biologics is accepting a limited amount of investments at $6.90 per share.
*Due to the demand for InSitu Biologics’ stock, and recent milestones achieved by the Company, InSitu intends to pause their Stock Offering on November 27, and submit a new price and value to the SEC. The Company believes the updated Stock Offering will again be available for purchase in January 2019. See the Manhattan Street Capital fees for this offering
View our Offering Circular HERE
Opu Labs - **Now a stock offering. Disrupting the global skin care industry via the blockchain and thier ingenious token reward system.
Opu Labs sophisticated token-based ecosystem pays users for participating at all levels. The company is showing excellent member traction worldwide with rapid growth and engagement. The Opu Labs Network leverages the blockchain well and is a thoroughly developed system.
**Opu Labs has switched from an ICO to a conventional Reg D stock offering. The new stock offering is live to accredited investors on Manhattan Street Capital at $1.40 per share. See the Manhattan Street Capital fees for this offering
Talketh - The first telephone network on the blockchain.
Talketh is a smartphone communications platform powered by the blockchain. Each member receives a crypto wallet on their phone with replacement service if needed. The company provides low-cost worldwide internet calling capabilities even on slow internet connections without the need for bank accounts; 1.5 Bill available market of consumers for this service. Each member receives a crypto wallet on their phone with replacement service if needed.
Talketh encourages their users to top-up call credits using their crypto-scratch-cards that are linked to the blockchain. Then, they not only supply them with a communications service, but they also reward them with a blockchain gift of crypto-tokens. Their Blockchain Scratch Cards are now in production.
Own the first Blockchain system to be approved by the Swiss Regulators using their Feb 2018 rules system. See the Manhattan Street Capital fees for this offering
Qmage - Own Augmented Digital Imaging
Each image becomes a standalone content store including text, audio, video, and URL. And the images can be shared in social media. Strong commercial use cases in six large and growing markets. See the Manhattan Street Capital fees for this offering
All the best,
Rod Turner is the founder and CEO of Manhattan Street Capital, the #1 Growth Capital marketplace for mature startups and mid-sized companies to raise capital using Regulation A+. Turner has played a key role in building successful companies including Symantec/Norton (SYMC), Ashton Tate, MicroPort, Knowledge Adventure and more. He is an experienced investor who has built a Venture Capital business (Irvine Ventures) and has made angel and mezzanine investments in companies such as Bloom, Amyris (AMRS), Ask Jeeves and eASIC.
Manhattan Street Capital, 5694 Mission Center Rd, Suite 602-468, San Diego, CA 92108.